IRESSA 250 (Iressa 250 mg)

Generic Name: gefitinib

Pill imprint IRESSA 250 has been identified as Iressa 250 mg.

Iressa is used in the treatment of non-small cell lung cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iressa 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Iressa

Generic Name:

gefitinib

Imprint:

IRESSA 250

Strength:

250 mg

Color:

Brown

Size:

11.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

EGFR inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

AstraZeneca Pharmaceuticals

National Drug Code (NDC):

00310-0482

Inactive Ingredients:

lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
povidone
sodium lauryl sulfate
magnesium stearate
hypromelloses
polyethylene glycol 300
titanium dioxide
ferric oxide red
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.